"Uncovering the Impact: Promising Advances and Bold Predictions for Long COVID"

Researchers are hopeful for progress in treating long COVID in 2024, with predictions including a better understanding of different long COVID phenotypes, the potential use of monoclonal antibodies to target viral persistence, the effectiveness of Paxlovid for long COVID treatment, the use of anti-inflammatories like metformin, and the potential role of serotonin levels and selective serotonin reuptake inhibitors (SSRIs) in alleviating long COVID symptoms.